Literature DB >> 11494333

Histamine H(1) receptor activation inhibits the proliferation of human prostatic adenocarcinoma DU-145 cells.

S Valencia1, A Hernández-Angeles, L E Soria-Jasso, J A Arias-Montaño.   

Abstract

BACKGROUND: Histamine stimulates cell proliferation in some tumor cell lines through the activation of H(1) receptors coupled to phosphoinositide hydrolysis. We therefore set out to study the presence of H(1) receptors in the prostate cancer cell line DU-145 and the effect of their stimulation on cell growth.
METHODS: The presence of histamine receptors was studied by radioligand binding. Phosphoinositide hydrolysis was assessed by measuring [(1)H]-inositol phosphate ([(1)H]-IPs) accumulation and changes in the intracellular concentration of free Ca(2+) ([Ca(2+)](i)). Proliferation was assessed by cell counting and by [(1)H]-thymidine incorporation.
RESULTS: DU-145 cells express H(1) receptors (110+/-14 fmol/mg of protein) whose stimulation results in [(1)H]-IPs accumulation (602+/-23% of basal, EC(50) 2.2+/-0.4 microM) and calcium mobilization (resting level 96+/-5 nM, Delta[Ca(2+)](i) 517+/-32 nM, EC(50) 6.2+/-0.1 microM). Incubation with histamine (100 microM, 24 hr) resulted in a decrease in both cell number and [(1)H]-thymidine incorporation, blocked by the H(1) antagonist mepyramine (1 microM).
CONCLUSIONS: Histamine inhibits the proliferation of DU-145 cells through the activation of H(1) receptors coupled to phosphoinositide hydrolysis. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11494333     DOI: 10.1002/pros.1096

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  4 in total

1.  The influence of craniofacial growth in a case of transverse facial cleft.

Authors:  Antje Kirbschus; Dietmar Gesch; Wolfram Kaduk; Tomasz Gedrange
Journal:  J Orofac Orthop       Date:  2006-05       Impact factor: 1.938

2.  Famotidine as a radioprotector for rectal mucosa in prostate cancer patients treated with radiotherapy: phase I/II randomized placebo-controlled trial.

Authors:  A Razzaghdoust; H Mozdarani; B Mofid
Journal:  Strahlenther Onkol       Date:  2014-03-12       Impact factor: 3.621

3.  Distinct roles of histamine H1- and H2-receptor signaling pathways in inflammation-associated colonic tumorigenesis.

Authors:  Zhongcheng Shi; Robert S Fultz; Melinda A Engevik; Chunxu Gao; Anne Hall; Angela Major; Yuko Mori-Akiyama; James Versalovic
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-11-21       Impact factor: 4.052

Review 4.  International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Authors:  Pertti Panula; Paul L Chazot; Marlon Cowart; Ralf Gutzmer; Rob Leurs; Wai L S Liu; Holger Stark; Robin L Thurmond; Helmut L Haas
Journal:  Pharmacol Rev       Date:  2015-07       Impact factor: 25.468

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.